Showing promise in the field of obesity therapy, retatrutide is a different approach. Different from many current medications, retatrutide works as a double agonist, simultaneously engaging both GLP peptide-1 (GLP-1) https://philipwyai356873.imblogs.net/88259797/a-novel-retatrutide-the-glp-gip-receptor-agonist